0001486634-19-000001.txt : 20190709 0001486634-19-000001.hdr.sgml : 20190709 20190709133428 ACCESSION NUMBER: 0001486634-19-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190709 DATE AS OF CHANGE: 20190709 EFFECTIVENESS DATE: 20190709 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ReNetX Bio, Inc. CENTRAL INDEX KEY: 0001486634 IRS NUMBER: 270687104 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-309612 FILM NUMBER: 19946871 BUSINESS ADDRESS: STREET 1: 157 CHURCH STREET STREET 2: 19TH FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: (203) 444-6642 MAIL ADDRESS: STREET 1: 157 CHURCH STREET STREET 2: 19TH FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06510 FORMER COMPANY: FORMER CONFORMED NAME: Axerion Therapeutics, Inc. DATE OF NAME CHANGE: 20100309 D/A 1 primary_doc.xml X0708 D/A LIVE 0001486634 ReNetX Bio, Inc. 157 CHURCH STREET 19TH FLOOR NEW HAVEN CT CONNECTICUT 06510 (203) 444-6642 DELAWARE Axerion Therapeutics, Inc. Corporation true Erika R. Smith 157 Church Street 19th Floor New Haven CT CONNECTICUT 06510 Executive Officer Director John Puziss c/o Yale University,Cooperative Research 2 Church Street South, Suite 203 New Haven CT CONNECTICUT 60519 Director David Wurzer c/o Connecticut Innovations,Incorporated 865 Brook Street Rocky Hill CT CONNECTICUT 06067 Director Biotechnology Decline to Disclose 06b true 0001486634-18-000001 2018-03-29 false true true false 0 3193548 3193548 0 false 6 0 0 0 No payments other than ordinary course employment compensation is being paid to executive officers. false ReNetX Bio, Inc. Erika R. Smith Erika R. Smith Chief Executive Officer 2019-07-09